Adezmapimod [CAS 152121-47-6]
Partner: MedChemexpress LLC
| CAS No: | 152121-47-6 |
| Applications: | COVID-19-immunoregulation |
| MW: | 377.43 |
| Formula: | C21H16FN3OS |
| SMILES: | O=S(C1=CC=C(C2=NC(C3=CC=C(F)C=C3)=C(C4=CC=NC=C4)N2)C=C1)C |
| Purity: | 99.96 |
| Description: | Adezmapimod (SB 203580) is a selective and ATP-competitive p38 MAPK inhibitor with IC50s of 50 nM and 500 nM for SAPK2a/p38 and SAPK2b/p38?2, respectively. Adezmapimod inhibits LCK, GSK3? and PKB? with IC50s of 100-500-fold higher than that for SAPK2a/p38. Adezmapimod does not disrupt JNK activity and is an autophagy and mitophagy activator[1]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
